Skeletal complications to a TREM2 variant associated with Alzheimer's Disease

与阿尔茨海默病相关的 TREM2 变异的骨骼并发症

基本信息

  • 批准号:
    10618952
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

SUMMARY Alzheimer's disease (AD) is a growing health concern and is the most common type of dementia worldwide. Veterans who have been prisoners of war have a 50% greater risk to develop dementia later in life, a percentage that becomes even higher in veterans who develop posttraumatic stress disorder. Evidence indicates that mental illness and neurological and nervous system disorders can increase the risk of developing osteoporosis leading to high prevalence of bone fractures. Fractures, in particular of the hip, have been associated with increased mortality, especially in the elderly. Conversely, osteoporosis is associated with increased risk of dementia diag- nosis. In spite all this evidence, a direct link between dementia and osteoporosis, frequently occurring with aging, has never been conclusively demonstrated. Interestingly, some genetic mutations are risk factors for both AD and osteoporosis. As an example, mutations of the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is expressed in microglia in brain and in osteoclasts in bone correlate with AD and dementia, and with bone fragility. Recent studies led by Dr. Landreth, a Consultant in this application, showed that mice expressing the R47H TREM2 variant (TREM2R47H/+ mice) exhibit loss of TREM2 function and neuritic dystrophy. However, the mechanisms responsible for the TREM2 mutation effects on bone mass and strength are completely unclear. In our preliminary findings, we showed that aged 13-month-old female TREM2R47H/+ mice exhibit a skeletal pheno- type, with decreased cortical and cancellous bone mass and cortical bone biomechanical properties. In addition, female, but not male showed reduced bone mineral density accrual between 1 and 12 months of age. Work of others showed that low bone mass in TREM2-/- mice is ascribed to low osteoclast β-catenin activation, suggesting defective canonical Wnt signaling in the absence of TREM2 function. Consistent with this possibility, expression of Wnt target genes cyclin D1 and Cx43 in tibia is lower in TREM2R47H/+ compared to WT mice, whereas cyclin D1, Lef1 and Axin2 expression is reduced in osteoclastic cells derived from bone marrow cells isolated from TREM2R47H/+ mice. On the other hand, osteoclastic constitutive β-catenin activation or expression of a high bone mass (HMB) LRP5 mutant decreased osteoclasts and increased bone mass in mice. Yet, the cellular and mo- lecular mechanisms for the changes in the bone mass and composition in TREM2R47H/+ mice remain unknown. Further, the role of low Wnt signaling on the skeletal effect of the TREM2 variant has not been tested. Based on our preliminary studies and on published evidence we propose that reduced Wnt/β-catenin signaling due to abnormal TREM2 function leads to increased osteoclastic bone resorption and results in skeletal defi- ciencies. To test this hypothesis we will 1. Investigate whether abnormal TREM2 function worsens the conse- quences of sex steroid removal in male and female adult mice, 2. Determine whether deletion of osteoclastic TREM2 is sufficient to elicit the skeletal phenotype observed in TREM2R47H/+ mice, and 3. Determine the role of osteoclastic Wnt/β-catenin signaling in the bone phenotype resulting from TREM2 deficiency. Successful com- pletion of these studies will widen our understanding of the cellular and molecular basis of the skeletal defects in mice with increased susceptibility to develop AD. Further, it might set the basis for treatments to improve both the cognitive and skeletal deficits in AD patients.
概括 阿尔茨海默病 (AD) 是一个日益严重的健康问题,也是全世界最常见的痴呆症类型。 成为战俘的退伍军人在以后的生活中患痴呆症的风险增加 50% 有证据表明,患有创伤后应激障碍的退伍军人的这一比例甚至更高。 疾病以及神经和神经系统疾病会增加患骨质疏松症的风险 骨折(尤其是髋部骨折)的高发生率与骨折的增加有关。 死亡率,尤其是老年人的死亡率,骨质疏松症与痴呆症诊断风险增加有关。 尽管有所有这些证据,但痴呆症和骨质疏松症之间存在直接联系,并且经常随着年龄的增长而发生。 统计数据尚未最终证明,某些基因突变是 AD 的危险因素。 例如,骨髓细胞 2 上表达的触发受体 (TREM2) 的突变。 在大脑中的小胶质细胞和骨骼中的破骨细胞中表达,与 AD 和痴呆相关,并且与骨骼相关 该应用的顾问 Landreth 博士最近领导的研究表明,小鼠表达 R47H TREM2 变异体(TREM2R47H/+ 小鼠)表现出 TREM2 功能丧失和神经性营养不良。 TREM2 突变对骨量和强度影响的机制尚不清楚。 我们的初步研究结果表明,13 个月大的雌性 TREM2R47H/+ 小鼠表现出骨骼现象 类型,皮质骨和松质骨量以及皮质骨生物力学特性降低。 女性(而非男性)在 1 至 12 个月大时表现出骨矿物质密度减少。 其他人表明,TREM2-/- 小鼠的低骨量归因于破骨细胞 β-连环蛋白激活率低,这表明 在缺乏 TREM2 功能的情况下,经典 Wnt 信号传导有缺陷,这与这种可能性一致。 与 WT 小鼠相比,TREM2R47H/+ 胫骨中 Wnt 靶基因 cyclin D1 和 Cx43 的含量较低,而 cyclin 源自骨髓细胞的破骨细胞中 D1、Lef1 和 Axin2 表达降低 另一方面,破骨细胞的β-连环蛋白激活或骨表达高。 Mass (HMB) LRP5 突变体减少了小鼠的破骨细胞并增加了骨量。 TREM2R47H/+ 小鼠骨量和骨成分变化的分子机制仍不清楚。 此外,低 Wnt 信号传导对 TREM2 变体骨骼效应的作用尚未得到测试。 我们的初步研究和已发表的证据表明,Wnt/β-连环蛋白信号传导的减少是由于 TREM2 功能异常导致破骨细胞骨吸收增加并导致骨骼缺陷 为了验证这一假设,我们将 1. 研究 TREM2 功能异常是否会导致结果恶化。 雄性和雌性成年小鼠中性类固醇去除的序列,2.确定破骨细胞是否缺失 TREM2 足以引发在 TREM2R47H/+ 小鼠中观察到的骨骼表型,并且 3. 确定 TREM2 缺陷导致的骨表型中破骨细胞 Wnt/β-catenin 信号传导成功。 这些研究的完成将扩大我们对骨骼缺陷的细胞和分子基础的理解 此外,它可能为改善这两种情况的治疗奠定基础。 AD 患者的认知和骨骼缺陷。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Messages from the Mineral: How Bone Cells Communicate with Other Tissues.
来自矿物质的信息:骨细胞如何与其他组织沟通。
  • DOI:
  • 发表时间:
    2023-07
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Plotkin, Lilian I;Sanz, Natasha;Brun, Lucas R
  • 通讯作者:
    Brun, Lucas R
Musculoskeletal Deficits and Cognitive Impairment: Epidemiological Evidence and Biological Mechanisms.
肌肉骨骼缺陷和认知障碍:流行病学证据和生物机制。
  • DOI:
  • 发表时间:
    2022-10
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Sui, Sophia X;Balanta;Pasco, Julie A;Plotkin, Lilian I
  • 通讯作者:
    Plotkin, Lilian I
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lilian Irene Plotkin其他文献

Lilian Irene Plotkin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lilian Irene Plotkin', 18)}}的其他基金

Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的影响
  • 批准号:
    10666647
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
  • 批准号:
    10508931
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的影响
  • 批准号:
    10666647
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
  • 批准号:
    10711910
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10408018
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10259555
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Osteocyte apoptosis and regulation of bone resorption with aging
衰老过程中骨细胞凋亡和骨吸收的调节
  • 批准号:
    9308117
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Osteocyte Apoptosis and Regulation of Bone Resorption with Aging
骨细胞凋亡和骨吸收随衰老的调节
  • 批准号:
    9212771
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    8241176
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    7461108
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Role of apoE-mediated meningeal lymphatic remodeling in the pathophysiology of Alzheimer’s disease
apoE 介导的脑膜淋巴重塑在阿尔茨海默病病理生理学中的作用
  • 批准号:
    10734287
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mediators of Muscle Rejuvenation with Aging
肌肉再生与衰老的调节剂
  • 批准号:
    10734927
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
  • 批准号:
    10588414
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Canagliflozin as a Neuroprotective Agent to Improve Neuroinflammation and Cognitive Function during Aging
卡格列净作为神经保护剂改善衰老过程中的神经炎症和认知功能
  • 批准号:
    10740151
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis
围绝经期啮齿动物模型中多巴胺系统功能异常:与精神病的相关性
  • 批准号:
    10585490
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了